ClinConnect ClinConnect Logo
Search / Trial NCT06338475

A Biobehavioral Intervention for Latino/Hispanic Young Adults with Cancer

Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Mar 23, 2024

Trial Information

Current as of August 21, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new therapy called Goal-focused Emotion-Regulation Therapy (GET) to see how it helps Latino/Hispanic young adults who have survived cancer. The goal is to reduce feelings of distress, improve how they handle their emotions, and teach them better ways to achieve their goals. Participants in the study will be randomly assigned to either receive GET or a similar support program called Instrumental Supportive Listening (ISL) over the course of eight weeks. Researchers will check in with participants at various times to see how they are feeling and to measure certain health markers.

To be eligible for this trial, participants need to be between 18 and 39 years old, identify as male, and have been diagnosed with cancer between the ages of 15 and 39. They should also be fluent in English or Spanish and have certain levels of distress or goal navigation skills. The trial is currently recruiting participants, and anyone who is interested should be aware that there are some health conditions that might prevent them from joining. This study aims to provide valuable insights that could help improve support for young adult cancer survivors in the future.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Age 18 to 39 years at time of consent
  • Male gender; self-identified
  • A confirmed diagnosis of cancer (any stage)
  • Diagnosed with cancer between the ages of 15 and 39
  • Hispanic/Latino identification
  • A score ≤ 1.8 on the Goal Navigation Scale or ≥ 4 on the Distress Thermometer
  • English or Spanish fluency
  • Exclusion Criteria:
  • lifetime history of bipolar disorder, schizophrenia, schizoaffective disorder (self-report)
  • compromised cognitive capacity
  • self-reported medical condition or medication use known to confound measures of systemic inflammation (e.g., autoimmune disorder, active infection)

About University Of California, Irvine

The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.

Locations

Irvine, California, United States

Patients applied

0 patients applied

Trial Officials

Michael A Hoyt, PhD

Principal Investigator

University of California, Irvine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported